RNTX·00887A204·US·Common Stock·Healthcare - Biotechnology-13D/G
RNTX (REIN THERAPEUTICS INC) is held by 14 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($448,185), STATE STREET CORP ($98,675), BlackRock, Inc. ($89,087). Net institutional sentiment: Mixed.
Showing 1-20 of 22
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer